Treatment for UTIs in Men
For urinary tract infections in men, the recommended treatment is a 7-14 day course of antibiotics, with first-line options including trimethoprim-sulfamethoxazole (TMP-SMX), nitrofurantoin, or fluoroquinolones based on local resistance patterns. 1
Diagnostic Approach
- Obtain urinalysis and urine culture before starting antibiotics
- Culture confirmation is essential for tailoring therapy based on bacterial sensitivities
- Treatment may be started empirically while awaiting culture results
Antibiotic Selection for Men with UTIs
First-Line Options
- Trimethoprim-sulfamethoxazole (TMP-SMX): 160/800 mg twice daily for 7-14 days
- Use only if local resistance is <20%
- Avoid in patients with sulfa allergies
- Nitrofurantoin: 100 mg twice daily for 7 days
- Contraindicated if CrCl <30 mL/min
- Highly effective against E. coli (which causes >75% of UTIs)
- Fluoroquinolones (e.g., levofloxacin): While generally reserved as second-line, may be appropriate first-line in men due to concerns about prostate involvement 1, 2
- Levofloxacin 250-500 mg once daily for 7-14 days
- Good penetration into prostatic tissue
Alternative Options
- Cephalexin: 500 mg four times daily for 7 days
- Amoxicillin-clavulanate: Based on susceptibility testing
- Fosfomycin: 3 g single dose, may require multiple doses for men
Important Considerations for Men with UTIs
Treatment Duration
- Men typically require longer treatment courses (7-14 days) than women with uncomplicated UTIs 1, 2
- This extended duration is due to the higher likelihood of complicated infection and potential prostatic involvement
Special Considerations
Prostate Involvement: UTIs in men often involve the prostate, requiring antibiotics with good prostatic penetration 2
- Fluoroquinolones achieve good prostatic concentrations
- For bacterial prostatitis, treatment duration may extend to 14-42 days 3
Renal Function: Adjust dosing based on creatinine clearance 1
- For levofloxacin:
- CrCl ≥50 mL/min: 500 mg once daily
- CrCl 26-49 mL/min: 500 mg once daily
- CrCl 10-25 mL/min: 250 mg once daily
- For levofloxacin:
Recurrent UTIs: Consider urologic evaluation to identify underlying structural abnormalities
Antibiotic Resistance Considerations
- Local antibiogram patterns should guide empiric therapy 1, 4
- Increasing resistance to TMP-SMX and aminopenicillins has been observed 2, 4
- Fluoroquinolones generally maintain good activity against uropathogens but should be used judiciously due to resistance concerns 4
Follow-up
- Monitor for symptom resolution within 48-72 hours
- If symptoms persist, reassess with repeat culture and consider urologic evaluation
- Consider imaging studies if recurrent infections or concern for anatomic abnormalities
Common Pitfalls
- Undertreating: Men require longer treatment courses than women with uncomplicated UTIs
- Missing prostatitis: Consider prostate involvement in all men with UTIs
- Ignoring resistance patterns: Local antibiograms should guide empiric therapy
- Inadequate follow-up: Men with UTIs may require urologic evaluation, especially with recurrent infections